Corindus Vascular Robotics (CVRS) Misses Q2 EPS by 2c, Revenues Beat; Agrees to be Acquired by Siemens Heathineers for $4.28/Sh

August 8, 2019 7:01 AM EDT Send to a Friend
Corindus Vascular Robotics (NYSE: CVRS) reported Q2 EPS of ($0.06), $0.02 worse than the analyst estimate of ($0.04). Revenue for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login